These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19455651)

  • 1. Multivessel disease in diabetics: does DES level the field?
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
    [No Abstract]   [Full Text] [Related]  

  • 2. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
    Hillegass WB
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):58-9. PubMed ID: 20578193
    [No Abstract]   [Full Text] [Related]  

  • 4. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
    [No Abstract]   [Full Text] [Related]  

  • 5. Two-stent technique: a dead duck or alive and kicking?
    Belardi JA
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
    [No Abstract]   [Full Text] [Related]  

  • 6. "Stick the landing," for optimal ostial placement of stents.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 May; 73(6):769-70. PubMed ID: 19367630
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
    [No Abstract]   [Full Text] [Related]  

  • 8. Off-label use and the spectre of drug-eluting stent thrombosis.
    Cook S; Wenaweser P
    Circ Cardiovasc Interv; 2009 Aug; 2(4):273-6. PubMed ID: 20031728
    [No Abstract]   [Full Text] [Related]  

  • 9. A sweet summer for drug-eluting stents in patients with diabetes mellitus.
    Costa MA
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):610-1. PubMed ID: 18949774
    [No Abstract]   [Full Text] [Related]  

  • 10. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
    Bailey SR
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
    [No Abstract]   [Full Text] [Related]  

  • 11. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 12. Noncardiac surgery after coronary stenting or angioplasty [corrected] .
    Tan WA
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):844-5. PubMed ID: 19902506
    [No Abstract]   [Full Text] [Related]  

  • 13. Time for left main stenting in patients with LV dysfunction? Proceed with caution!
    Uretsky BF
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):594-5. PubMed ID: 20333658
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug eluting stents in AMI: keep the data coming.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
    [No Abstract]   [Full Text] [Related]  

  • 15. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel use in diabetic patients with new stents.
    Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
    [No Abstract]   [Full Text] [Related]  

  • 17. Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):32-3. PubMed ID: 19089933
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
    [No Abstract]   [Full Text] [Related]  

  • 19. SES for AMI: moving in the right direction.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
    [No Abstract]   [Full Text] [Related]  

  • 20. TCT Daily: ESTROFA: late thrombosis not increased in DES patients: Spanish registry of drug-eluting stents shows STEMI, LAD artery lesions, significant risk factors.
    Kahn J
    J Interv Cardiol; 2007 Feb; 20(1):32. PubMed ID: 17300396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.